SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-22-092417
Filing Date
2022-04-01
Accepted
2022-03-31 21:43:06
Documents
19
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d328059d10ka.htm   iXBRL 10-K/A 98453
2 EX-4.1 d328059dex41.htm EX-4.1 37703
3 EX-21.1 d328059dex211.htm EX-21.1 1984
4 EX-31.3 d328059dex313.htm EX-31.3 3353
5 EX-31.4 d328059dex314.htm EX-31.4 3410
  Complete submission text file 0001193125-22-092417.txt   358119

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA tpst-20211231.xsd EX-101.SCH 5189
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tpst-20211231_cal.xml EX-101.CAL 931
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tpst-20211231_def.xml EX-101.DEF 1934
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE tpst-20211231_lab.xml EX-101.LAB 22489
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tpst-20211231_pre.xml EX-101.PRE 17909
13 EXTRACTED XBRL INSTANCE DOCUMENT d328059d10ka_htm.xml XML 8145
Mailing Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT SUITE 275 SOUTH SAN FRANCISCO CA 94080 415-798-8589
Tempest Therapeutics, Inc. (Filer) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-35890 | Film No.: 22795533
SIC: 2834 Pharmaceutical Preparations